139 related articles for article (PubMed ID: 24158603)
1. Treatment of astrocytoma grade III with Photofrin II as a radiosensitizer. A case report.
Schaffer M; Hofstetter A; Ertl-Wagner B; Batash R; Pöschl J; Schaffer PM
Strahlenther Onkol; 2013 Nov; 189(11):972-6. PubMed ID: 24158603
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cervix carcinoma FIGO IIIb with Photofrin II as a radiosensitizer: a case report.
Schaffer P; Batash R; Ertl-Wagner B; Hofstetter A; Asna N; Schaffer M
Photochem Photobiol Sci; 2019 May; 18(5):1275-1279. PubMed ID: 30892313
[TBL] [Abstract][Full Text] [Related]
3. The Application of Photofrin II as a sensitizing agent for ionizing radiation--a new approach in tumor therapy?
Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Jori G; Dühmke E; Hofstetter A
Curr Med Chem; 2005; 12(10):1209-15. PubMed ID: 15892632
[TBL] [Abstract][Full Text] [Related]
4. Application of Photofrin II as a specific radiosensitising agent in patients with bladder cancer--a report of two cases.
Schaffer M; Schaffer PM; Vogesser M; Ertl-Wagner B; Rauch J; Oberneder R; Jori G; Hofstetter A; Dühmke E
Photochem Photobiol Sci; 2002 Sep; 1(9):686-9. PubMed ID: 12665306
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of photofrin II as a radiosensitizing agent in solid tumors--preliminary results.
Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Jori G; Wilkowski R; Hofstetter A; Dühmke E
Onkologie; 2006 Nov; 29(11):514-9. PubMed ID: 17068386
[TBL] [Abstract][Full Text] [Related]
6. Photofrin as a radiosensitizer in an in vitro cell survival assay.
Kulka U; Schaffer M; Siefert A; Schaffer PM; Olsner A; Kasseb K; Hofstetter A; Dühmke E; Jori G
Biochem Biophys Res Commun; 2003 Nov; 311(1):98-103. PubMed ID: 14575700
[TBL] [Abstract][Full Text] [Related]
7. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model.
Schaffer M; Schaffer PM; Corti L; Gardiman M; Sotti G; Hofstetter A; Jori G; Dühmke E
J Photochem Photobiol B; 2002 Apr; 66(3):157-64. PubMed ID: 11960724
[TBL] [Abstract][Full Text] [Related]
8. Development of anaplastic changes in low-grade astrocytomas of childhood.
Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
[TBL] [Abstract][Full Text] [Related]
9. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
Sullivan FJ; Herscher LL; Cook JA; Smith J; Steinberg SM; Epstein AH; Oldfield EH; Goffman TE; Kinsella TJ; Mitchell JB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):583-90. PubMed ID: 7928489
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy combined with photofrin or 5-ALA: effect on Lewis sarcoma tumor lines implanted in mice. Preliminary results.
Schaffer M; Schaffer PM; Jori G; Corti L; Sotti G; Hofstetter A; Dühmke E
Tumori; 2002; 88(5):407-10. PubMed ID: 12487560
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of predictors influencing the results of the combined treatment for anaplastic astrocytomas (grade III) of the brain].
Solodky VA; Panshin GA; Bychkov YM; Anashkina MV; Milyukov SM; Izmailov TR
Vopr Onkol; 2015; 61(1):25-30. PubMed ID: 26016141
[TBL] [Abstract][Full Text] [Related]
13. [Effect of BAR therapy in a case of malignant glioma with extracranial metastasis].
Kanno T; Moriyama M; Kagawa M; To T; Ishimori S
No To Shinkei; 1970 Oct; 22(10):1187-91. PubMed ID: 5536188
[No Abstract] [Full Text] [Related]
14. [Radiotherapy of brain astrocytomas and oligodendrogliomas of the adult].
Mazeron JJ; Simon JM; Noël G; Proudhom MA; Renard A
Cancer Radiother; 2000 Nov; 4 Suppl 1():53s-66s. PubMed ID: 11194965
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of outcomes after stereotactic radiosurgery for pilocytic astrocytoma.
Trifiletti DM; Peach MS; Xu Z; Kersh R; Showalter TN; Sheehan JP
J Neurooncol; 2017 Sep; 134(2):297-302. PubMed ID: 28567590
[TBL] [Abstract][Full Text] [Related]
16. Photofrin II as an efficient radiosensitizing agent in an experimental tumor.
Schaffer M; Schaffer PM; Corti L; Sotti G; Hofstetter A; Jori G; Dühmke E
Onkologie; 2001 Oct; 24(5):482-5. PubMed ID: 11694776
[TBL] [Abstract][Full Text] [Related]
17. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
[TBL] [Abstract][Full Text] [Related]
18. BUdR radiosensitization in anaplastic astrocytoma.
Yung WK
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1105-6. PubMed ID: 10613300
[No Abstract] [Full Text] [Related]
19. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
20. On the double role of photofrin as a photo- and a radio-sensitising agent: a possible new combination therapy for tumours.
Schaffer M; Schaffer PM; Hofstetter A; Dühmke E; Jori G
Photochem Photobiol Sci; 2002 Jun; 1(6):438-9. PubMed ID: 12856714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
